Absence of TERT promoter mutations in esophageal adenocarcinoma
Nistelrooij, A.M.J., Zwarthoff, E.C., Post, E., Lurkin, I., Marion, R., Kopershoek, E., Biermann, K., Wijnhoven, B.P.L., Dinjens, W.N.M.
Published in International journal of cancer (15.04.2014)
Published in International journal of cancer (15.04.2014)
Get full text
Journal Article
Absence of BRAF and HRAS mutations in eruptive Spitz naevi
Gantner, S., Wiesner, T., Cerroni, L., Lurkin, I., Zwarthoff, E.C., Landthaler, M., Hafner, C.
Published in British journal of dermatology (1951) (01.04.2011)
Published in British journal of dermatology (1951) (01.04.2011)
Get full text
Journal Article
837 Improved diagnostic urine assay to select patients for initial cystoscopy
Van Kessel, K.E.M, Beukers, W, Lurkin, I, Van Der Keur, K.A, Dyrskjot, L, Segersten, U, Ørntoft, T.F, Malats, N, Malmström, P.U, Real, F.X, Bangma, C.H, Zwarthoff, E.C
Published in European urology supplements : official journal of the European Association of Urology (01.04.2015)
Published in European urology supplements : official journal of the European Association of Urology (01.04.2015)
Get full text
Journal Article
Absence of TERT promoter mutations in esophageal adenocarcinoma: Letter to the Editor
van Nistelrooij, A.M.J., Zwarthoff, E.C., Post, E., Lurkin, I., van Marion, R., Kopershoek, E., Biermann, K., Wijnhoven, B.P.L., Dinjens, W.N.M.
Published in International journal of cancer (15.04.2014)
Published in International journal of cancer (15.04.2014)
Get full text
Journal Article
The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate
VAN RHIJN, Bas W. G, LURKIN, Irene, RADVANYI, Francois, KIRKELS, Wim J, VAN DER KWAST, Theodorus H, ZWARTHOFF, Ellen C
Published in Cancer research (Chicago, Ill.) (15.02.2001)
Get full text
Published in Cancer research (Chicago, Ill.) (15.02.2001)
Journal Article
Abstract P3-06-01: Hotspot mutations in PIK3CA are predictive for treatment outcome on aromatase inhibitors but not for tamoxifen
Ramirez, Ardila DE, Helmijr, JC, Lurkin, I, Look, M, Ruigrok-Ritstier, K, Simon, I, Van Laere, S, Sweep, F, Span, P, Linn, S, Foekens, J, Sleijfer, S, Berns, EMJJ, Jansen, MPHM
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
39 Mutaties in PIK3CA en FGFR3 correleren met een gunstige prognose na radicale cystectomie voor het spierinvasief blaascarcinoom
Lely, F.C., Zuiverloon, T.C.M., Boormans, J.L., Abas, C., Lurkin, I., Roshani, H., Oomens, E., van der Hoeven, J., Boevé, E., Zwarthoff, E.C.
Published in Tijdschrift voor urologie (01.05.2014)
Published in Tijdschrift voor urologie (01.05.2014)
Get full text
Journal Article
264 - 20-gene expression signature to predict lymph node positive disease at radical cystectomy for muscle-invasive bladder cancer: Not validated
Van Kessel, K., Van De Werken, H., Lurkin, I., Ziel–Van Der Made, A., Zwarthoff, E., Boormans, J.
Published in European urology supplements : official journal of the European Association of Urology (01.03.2017)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2017)
Get full text
Journal Article